MRNA · Moderna, Inc.
$63.32
-0.33 (-0.52%)
At close · Aug 14
Market Cap
$25.28B
Shares
399.24M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Utilization
43.3%
$1,300,000,000 used of $3,000,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-08-01 | $3,000,000,000 | $1,700,000,000 | 2026-06-30 | — | 10-Q , filed 2026-07-31 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 | $2,000,000 | 10-K, filed 2026-02-20 | ||
| 2024-12-31 | $0 | 10-K, filed 2026-02-20 | ||
| 2023-12-31 | $1,153,000,000 | 10-K, filed 2026-02-20 | ||
| 2022-12-31 | $3,329,000,000 | 10-K, filed 2025-02-21 | ||
| 2021-12-31 | $857,000,000 | 10-K, filed 2024-02-23 | ||
Key facts
CIK
1682852
CUSIP
60770K107
13F (30d)
727 filings
689 filers
Visit website
Investor relations